NKGen Biotech, Inc. Common Stock (NKGN)

USD 0.49

(8.26%)

Market Cap (In USD)

17.41 Million

Revenue (In USD)

-

Net Income (In USD)

-82.95 Million

Avg. Volume

910.83 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.203-4.06
PE
-
EPS
-
Beta Value
0.524
ISIN
US65488A1016
CUSIP
-
CIK
1845459
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Paul Y. Song M.D.
Employee Count
-
Website
https://www.grafacq.com
Ipo Date
2023-10-02
Details
Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Graf Acquisition Corp. IV was incorporated in 2021 and is based in The Woodlands, Texas.